Mainolfi Nello's Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Feb 25, 2026
- Accession no.
- 0001193125-26-072155
- Filed
- Feb 25, 2026
- Trade date
- Feb 25, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.71M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mainolfi NelloCIK 0001821189 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock | MOption exerciseAcquired | +30,000 | $2.08 | +$62,400 | 696,195 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −19,764 | $89.78 | −$1,774,411.92 | 676,431 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −5,434 | $90.39 | −$491,179.26 | 670,997 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −3,293 | $91.76 | −$302,165.68 | 667,704 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −1,501 | $92.81 | −$139,307.81 | 666,203 | Direct | |
| Feb 25, 2026 | Common Stock | SSaleDisposed | −8 | $93.49 | −$747.92 | 666,195 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 245,559 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.